Skip to main content
. 2012 Mar 7;7(3):e33316. doi: 10.1371/journal.pone.0033316

Table 5. CpG DNA methylation in B19V DNA present in clinical samples.

Sample (Date) Tissue Clinical setting Viral load Met Index
A.29 (07/09/2008) Placenta IUFD 1.36E+03 0.111
GA.1 (06/07/2006) Placenta IUFD 6.33E+06 <0.001
BE.1 (12/06/2007) Duodenum Aplastic crisis 6.97E+03 0.005
AP.1 (02/03/2005) Ileum IBD ND ND
AP.2 (20/10/2005) Ileum IBD ND ND
CM.1 (15/01/2009) Myocardium Myocarditis 1.08E+03 0.136
CM.2 (18/02/2009) Myocardium Myocarditis 3.17E+02 0.287
FV.1 (19/04/2010) Myocardium Myocarditis 7.62E+03 0.511
ML.1 (21/02/2005) Myocardium Myocarditis 2.43E+02 0.268
ML.2 (23/02/2005) Myocardium Myocarditis 1.06E+03 0.296
ML.3 (09/03/2005) Myocardium Myocarditis 6.09E+04 0.004
MN.1 (08/11/2005) Myocardium Myocarditis 4.00E+03 0.423
MN.2 (23/11/2005) Myocardium Myocarditis 2.33E+03 0.714
MN.3 (04/01/2007) Myocardium Myocarditis 4.76E+03 0.605

Clinical samples, amount of viral DNA present in tissues (genome copies/100 ng cellular DNA) and analysis of methylation status of viral DNA as determined by MSP assay. IUFD: intrauterine fetal death; IBD: inflammatory bowel disease; ND: not determined.